SLU PP 332 1.3mg Peptide Pen boosts mitochondrial function and energy in approximately 26 doses per pen at 9 clicks per dose without muscle loss.

Product Name: SLU-PP-332 Pen

Formulation: 2.6 mL pre-filled pen

Clicks per Pen: 240

Total Amount: 1.3 mg SLU-PP-332

Supplied with: 6 sterile needles (extras available)

Key Benefits

Fat Loss & Weight Management: Studies on obese mice showed significant reductions in fat mass gain. The drug prompts the body to use fat as its primary fuel source, essentially mimicking the metabolism of someone continuously exercising.
Enhanced Endurance & Stamina: SLUPP-332 activates biological pathways that naturally respond to exercise, enabling normal-weight mice to run 70% longer and 45% further than untreated subjects.
Mitochondrial Biogenesis: It promotes the growth and efficiency of mitochondria—the powerhouses of your cells—boosting cellular energy output and increasing overall oxygen capacity (VO2 max).
Improved Metabolic Health: In models of metabolic syndrome, it has been shown to improve insulin sensitivity and decrease fat accumulation in the liver.
Potential AntiAging & Cardioprotective Effects: Early research indicates potential in reducing ageassociated inflammatory markers, supporting cellular autophagy, and improving cardiac contractility

Description

SLU-PP-332 is a first-in-class synthetic small-molecule pan-agonist of estrogen-related receptors (ERRA, ERRẞ, and ERRY). It is a non-steroidal, non-endocrine-disrupting compound belonging to the class of ERR agonists. Chemical name: 4-hydroxy-N-(4-(2-(4-hydroxyphenyl)propan-2-yl)phenyl)benzamide (or structural analog thereof; exact proprietary structure is patented by Saint Louis University). SLU-PP-332 is orally bioavailable, metabolically stable, and designed to selectively activate ERRS without binding classical estrogen receptors (ERa/ERẞ).

Mechanism of Action

SLU-PP-332 binds directly to the ligand-binding domain of ERRA, ERRẞ, and ERRY, inducing conformational changes that promote coactivator recruitment (e.g., PGC-1a) and transcriptional activation of ERR target genes. Key downstream effects include:

Upregulation of mitochondrial biogenesis and oxidative phosphorylation genes
Increased expression of fatty acid oxidation enzymes and mitochondrial uncoupling proteins
Enhanced type I (slow-twitch, oxidative) muscle fibre gene programs
Improved exercise endurance capacity and metabolic flexibility
Activation of energy expenditure pathways independent of classical estrogen signalling
The compound induces an “exercise-like” molecular signature in skeletal muscle, liver, adipose tissue, and brain, mimicking many of the metabolic adaptations seen with chronic physical training.

Indications & Usage

SLU-PP-332 is used to support mitochondrial function, metabolic health, and exercise-like adaptations. It is indicated for:

Enhancement of mitochondrial biogenesis and cellular energy production
Promotion of fat oxidation, metabolic efficiency, and insulin sensitivity
Support for endurance capacity, muscle oxidative phenotype, and recovery from metabolic stress
Assistance in age-related or inactivity-related decline in mitochondrial and metabolic performance

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you.

SLU-PP-332

R 920,00

Quantity

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to SLU-PP-332 or any excipient

Active malignancy (theoretical concern regarding enhanced cellular metabolism)

Severe uncontrolled hepatic or renal impairment

Pregnancy or breastfeeding

Age under 18 years

Warnings

Use only under medical supervision with periodic monitoring (glucose metabolism, liver function, lipid profile, and clinical parameters).

Not a substitute for physical exercise, diet, or approved therapies for metabolic disorders.

High doses may cause transient gastrointestinal discomfort, flushing, or changes in energy levels.

Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe abdominal pain, allergic reaction, or unexpected neurological changes).

Side Effects

SLU-PP-332 is generally well tolerated in preclinical models. Human data are limited; potential adverse reactions may include:

Mild injection-site irritation, redness, or itching

Transient headache, light-headedness, or flushing

Temporary gastrointestinal discomfort (nausea, bloating)

Rare fatigue or changes in energy levels during initial use

If any severe or persistent symptoms occur (e.g., severe headache, abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately.
Dosage & Administration

Subcutaneous injection only.

Standard Dose: 1.3 mg per injection (full pen content per dose; typically, 240 clicks = 1.3 mg)

Frequency: Once daily or 3-5 times per week (depending on protocol and tolerance)

Timing: Morning or pre–activity to maximize energy and metabolic effects

Cycle: Typically, 4-12 weeks on, followed by 4 weeks off to maintain efficacy

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks (full dose = 240 clicks for 1.3 mg).

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C/77-86°F).

Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

SLU-PP-332

Contraindications & Warnings

Dosage, Administration, Storage & Handling

Important notice

Best sellers

Optimal Whey 1kg - Chocolate Ice Cream Flavour

Creatine Monohydrate

L-Glutamine

Skin Glow (GHK-CU)